(This measure has not been amended since it was introduced. The summary of that version is repeated here.)
Waives a specified requirement of Rule XIII (Calendar and Committee Reports) to allow consideration of a bill (amending the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and for medical devices, and to enhance the postmarket authorities of the Food and Drug Administration (FDA) with respect to the safety of drugs) on the same day it is presented to the House.
Motion to reconsider laid on the table Agreed to without objection.
Introduced in House
The House Committee on Rules reported an original measure, H. Rept. 110-332, by Mr. Arcuri.
The House Committee on Rules reported an original measure, H. Rept. 110-332, by Mr. Arcuri.
Waiving a requirement of clause 6(a) of rule XIII with respect to consideration of certain resolutions reported from the Committee on Rules.
Placed on the House Calendar, Calendar No. 116.
Pursuant to the provisions of H. Res. 677, H. Res. 659 is laid on the table.
checking server…
Ask anything about this bill. The AI reads the full text to answer.
Enter to send · Shift+Enter for new line